Cargando…

Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy

PURPOSE: Cisplatin (CDDP) and etoposide (Etp) are recommended first-line therapy for lung cancer. Nanostructured lipid carriers (NLCs) are engineered to deliver drugs for lung cancer treatment. In the present study, NLCs were applied to coload an Etp prodrug (EtpP) and CDDP. METHODS: The Etp prodrug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Min, Yin, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733446/ https://www.ncbi.nlm.nih.gov/pubmed/36506793 http://dx.doi.org/10.2147/DDDT.S386100

Ejemplares similares

Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
por: Zhang, Jicai, et al.
Publicado: (2018)

In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide–Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis
por: Raza, Hassan, et al.
Publicado: (2022)

Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers
por: You, Peijun, et al.
Publicado: (2017)

A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer
por: Chen, Chuanrong, et al.
Publicado: (2021)

Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity
por: Yang, Feng, et al.
Publicado: (2018)

Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy
por: Qu, Chun-Ying, et al.
Publicado: (2015)

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997)

Lymph cancer chemotherapy: delivery of doxorubicin–gemcitabine prodrug and vincristine by nanostructured lipid carriers
por: Ni, Shuqin, et al.
Publicado: (2017)

Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
por: Liu, Jia, et al.
Publicado: (2018)

Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer
por: Bouzo, Belén L., et al.
Publicado: (2021)

Synergistic anti-glioma effect of a coloaded nano-drug delivery system
por: Xu, Huae, et al.
Publicado: (2016)

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
por: Selvamuthukumar, Subramanian, et al.
Publicado: (2012)

Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect
por: Xu, Man, et al.
Publicado: (2020)

Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo
por: Yang, Lu, et al.
Publicado: (2021)

Comparative Dose–Response Study on the Infusion of Norepinephrine Combined with Crystalloid Coload versus Colloid Coload for Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery
por: Jin, Wei-dong, et al.
Publicado: (2022)

Atomic-Scale Modeling of Nanosystems and Nanostructured Materials
por: Massobrio, Carlo, et al.
Publicado: (2010)

Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery
por: Li, Hao, et al.
Publicado: (2023)

An Exceptionally Favorable Response to Etoposide and Cisplatin
por: Valecha, Gautam, et al.
Publicado: (2015)

A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform
por: Yu, Yibin, et al.
Publicado: (2019)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer
por: Watanabe, R, et al.
Publicado: (2003)

Dual Nanostructured Lipid Carriers/Hydrogel System for Delivery of Curcumin for Topical Skin Applications
por: Calderon-Jacinto, Rosa, et al.
Publicado: (2022)

Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
por: Chauhan, Iti, et al.
Publicado: (2020)

Editorial on Special Issue “Lipid Nanosystems for Local Drug Delivery”
por: Catita, José, et al.
Publicado: (2023)

An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD
por: Su, Wenting, et al.
Publicado: (2023)

A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy
por: Wang, Yifan, et al.
Publicado: (2019)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
por: Berghmans, Thierry, et al.
Publicado: (2017)

A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression
por: Zhou, Yi, et al.
Publicado: (2023)

An ATF(24) peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
por: Zhai, Bingtao, et al.
Publicado: (2020)

Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers
por: Liu, Youqiang, et al.
Publicado: (2022)

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022)

Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms
por: Gugleva, Viliana, et al.
Publicado: (2023)

Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures
por: Wang, Mengjie, et al.
Publicado: (2022)

Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
por: Lin, Yin-Ku, et al.
Publicado: (2010)

Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
por: Khan, Saba, et al.
Publicado: (2015)

Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs
por: Choi, Kyeong-Ok, et al.
Publicado: (2016)

Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis
por: Ahmadpour, Ehsan, et al.
Publicado: (2019)

Nanostructured Lipid Carriers-Hydrogels System for Drug Delivery: Nanohybrid Technology Perspective
por: Syed Azhar, Sharifah Nurfadhlin Afifah, et al.
Publicado: (2022)

Preclinical Evaluation of Lipid-Based Nanosystems
por: Silva, Ana Catarina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_061gosugcuhdpjkk9u8m58s7qa